News 
Market Data 
Discover
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
$RSCI$$$$ can't believe actually making money on a reverse splitted pos stock!!
$RSCI back to $1 again but now offered $1.05
|
Followers
|
216
|
Posters
|
|
|
Posts (Today)
|
0
|
Posts (Total)
|
34573
|
|
Created
|
05/08/08
|
Type
|
Free
|
| Moderators | |||
Redwood Scientific Technologies (OTC:RSCI)
Develops and markets FDA registered homeopathic drugs through the application of sublingual strip delivery
Redwood Scientific Technologies, Inc. develops and markets FDA registered over-the-counter drugs that features oral strip delivery technology. Oral strip delivery technology has emerged as an advanced alternative to the traditional tablets, capsules, and liquid medications. Similar in size, shape, and thickness to a postage stamp, oral strips are typically designed for oral administration and work by having the user place the strip on or under the tongue.
These drug delivery options allow the medication to bypass the first pass metabolism thereby making the medication more bioavailable. As the strip dissolves, the drug can enter the bloodstream enterically, buccally or sublingually.
View The End Of The Pill Corporate Video: click here
Phone: (310) 693-5401
Email: info@redwoodscientific.co
To request FREE information click here
Founder of Redwood Scientific Technologies. Founder of First Choice Media. Managed $100M advertising budget. Co-founder of Runaway Products. Developed and launched 7 top 10 infomercials. Founder of Top 5 most recognizable brands in the UK in 2009.
Managing director for Canella Direct response media. Ran national ad campaigns for Guthy Renker. Co-founder of Runaway Products.
ALBANY, New York, May 31, 2017 /PRNewswire/ --
North America to Lead Global Thin Film Drug Manufacturing Market
LOS ANGELES, August 21, 2017 /PRNewswire/ -- Redwood Scientific Technologies, Inc (RST) the leader in over-the-counter medication delivered in an oral thin-film strip has announced the rapid introduction of new products to the marketplace over the next three quarters.
Redwood Scientific Technologies will be delivering three new products in Q3 of 2017 that will introduce industry-leading scientific advances. Vita-Balance, an adult multi-vitamin, will launch first, representing an enormous breakthrough in the oral thin-film delivery method. It will be the first time the amount of active ingredients has been synthesized down to the dosage required to create an effective, active thin-film strip. Next, RST will launch Capilli-Biotin RX, a hair-growth product that will also include huge benefits for skin and nails. The final product for Q3 will be Ocean-X, with the active ingredient Medazine, which will work to combat motion sickness and nausea. As an oral strip, it will bypass the need to be chewed, then placed under the tongue, for effectiveness.
Jason Cardiff, the company’s founder and CEO, stated, “I am very excited about the next 36 months and the ramp rate and growth of our new products coming to market. We continue to see massive growth in our over-the-counter drugs and look forward to the expansion with new products.
RST has planned to bring nine new products to market by the end of Q4, and is expected to announce the introduction of the company’s first line of children’s products in Q4 as well. By the end of Q3 of 2018, the company is hoping to bring over 20 new products to market each quarter, with a projected growth plan of 200 oral thin-film strip products by the end of 2018. Redwood Scientific Technologies has also reported they are on track to develop the first oral thinfilm strip to be delivered as a prescription-only treatment for internal infections. In addition, the company’s science team has reported new developments in creating an oral thin-film strip that will hold antibiotics. RST’s head of pediatric treatments, Dr. Oyemade, stated, “This will be the greatest treatment and delivery method we have seen in modern medicine in over 100 years.”
LOS ANGELES, May 1, 2017 /PRNewswire/ -- Redwood Scientific Technologies, Inc (RST) announces that is has started the beginning stages of bringing antibiotics to market in the successful oral thin film method.
It will be the first RST products that is not over the counter and will require a prescription. The first antibiotic will be Azithromycin. The company has stated they have already started the FDA process and is in its initial testing. RST has achieved the same successful results in combining the active ingredient into the OTF strip verses the tablet form. RST also believes that it could have products on the shelf in pharmacies by the third quarter of 2019. This will be the first of several prescriptions based applications to be developed by the world leader in OTF medication.
LOS ANGELES, April 1, 2017 /PRNewswire/ -- Redwood Scientific Technologies, Inc (RST) is launching its latest product, Eupepsia Thin.
Redwood Scientific Technologies, Inc (RST) is launching its latest product, Eupepsia Thin. Like all RST products, it is an OTF based product (oral thin film). It will dissolve in your mouth in about 20 seconds and from there works to suppress your appetite and creates a feeling of fullness. The Chief Medical Officer at RST states that, the issue we have with obesity and the lack of successful dieting is the that we are consuming 2,500 plus more calories per day than we are expending. With Eupepsia Thin, you have the desire to eat less even when you are confronted with foods you love in super-sized portions.
Redwood believes that, with healthy eating and average exercise, their new product Eupepsia Thin is the answer to the diet roller coaster.
LOS ANGELES, April 6, 2016 /PRNewswire/ -- Redwood Scientific Technologies, Inc. today announced that it has sold over 10,000 units of TBX-FREE since the product first launched in December of 2015.
"We are incredibly proud of the progress TBX-FREE has made in helping smokers around the world quit their harmful addiction to cigarettes," said Jason Cardiff, President and CEO. "Smokers are clearly responding well to the benefits offered by the oral strip delivery technology that is in TBX-FREE. Simply put: pills, patches, and lozenges are obsolete methods of drug delivery, and given the high number of smokers who fail at quitting; they clearly are ineffective."
According to the CDC, there are an estimated 40 million smokers within the United States. With such a large amount of potential customers, TBX-FREE is poised to obtain a huge market presence by providing an effective alternative to nicotine replacement therapy. Even more noteworthy is that TBX-FREE has passed the 10,000 units sold mark in the space of only 3 months.
Additionally, customers who complete their first month of TBX-FREE will now receive supplemental material that includes instructions for after their first 30 days, important information on smoking recurrence, a certificate of completion, and other helpful items.
About Redwood Scientific Technologies, Inc.
Redwood Scientific Technologies, Inc. (Redwood), headquartered in Claremont, California, develops and markets FDA registered OTC drugs that can be delivered through the use of thin film technology. Redwood utilizes patent pending sublingual strip delivery technology to enhance the effectiveness and absorption rate in the treatment of medical conditions. The company is aggressively expanding its customer population through national television advertising campaigns while driving consumer awareness and increasing retail expansion.
LOS ANGELES, March 4, 2016 /PRNewswire/ -- Redwood Scientific Technologies, Inc. today announced that it has appointed M. Salah Zaki, M.D., as Chief Medical Officer. In this role, Dr. Zaki will oversee scientific research, assist with FDA registration, medical regulation, product development, and global expansion.
"Dr. Zaki brings a vast wealth of medical experience to Redwood during a time when our company is rapidly growing," said Jason Cardiff, President and CEO. "His recruitment as Chief Medical Officer represents our confidence that not only will the company produce incredibly sophisticated products in the future but also that our growth necessitates additional scientific expertise. With the aid of his impressive international experience, Redwood Scientific Technologies will be positioned to expand into foreign markets."
Dr. Zaki joins Redwood from his previous position as the President and CEO of International Medical Consultants. He graduated 6th in his class from the prestigious Al Azhar University Medical School in Cairo, Egypt. As a cardiac surgeon, he has integrated Western medical practices into his work throughout the Middle East. In 2009, he was appointed by the U.S. Embassy in Egypt to be the official medical liaison during President Barack Obama's visit. From 1995-2006, he was Medical Director of the International Department of the Washington Hospital Center. In 1995, Dr. Zaki developed an international patient program to expand the Washington Hospital Center's communications worldwide. In 2001, he was appointed as the first President of the Institute of International Health at the George Washington University Medical Center and also as Medical Director of the International Program at Georgetown University Hospital. He has also served as medical advisor to the Armed Forces of the UAE.
About Redwood Scientific Technologies, Inc.
Redwood Scientific Technologies, Inc. (Redwood), headquartered in Claremont, California, develops and markets FDA registered OTC drugs that can be delivered through the use of thin film technology. Redwood utilizes patent pending sublingual strip delivery technology to enhance the effectiveness and absorption rate in the treatment of medical conditions. The company is aggressively expanding its customer population through national television advertising campaigns while driving consumer awareness and increasing retail expansion.
LOS ANGELES, Feb. 12, 2016 /PRNewswire/ -- Redwood Scientific Technologies, Inc. (Redwood) today announced the unveiling of Blossom: a new oral strip product designed to balance hormones in women.
"Blossom will take the female personal care market by storm and give women the power to enjoy balanced hormones," said Jason Cardiff, President and CEO. "Millions of women around the nation and throughout the world will enjoy more satisfying sex lives, more powerful orgasms, and improved libidos. Now women will have the opportunity to improve their sexual performance."
Using Redwood Scientific Technologies' advanced oral strip delivery technology, Blossom can help women get immediate hormone balancing benefits. Ingredients inside Blossom include fenugreek extract, L-arginine, and red ginseng. When combined together, these ingredients can increase the sexual pleasure women enjoy by balancing their hormones and allowing greater sensitivity during intercourse along with increased arousal.
A marketing and advertising campaign for Blossom is expected to launch in the second quarter of 2016.
About Redwood Scientific Technologies, Inc.
Redwood Scientific Technologies, Inc. (Redwood), headquartered in Claremont, California, develops and markets FDA registered OTC drugs that can be delivered through the use of thin film technology. Redwood utilizes patent pending sublingual strip delivery technology to enhance the effectiveness and absorption rate in the treatment of medical conditions. The company is aggressively expanding its customer population through national television advertising campaigns while driving consumer awareness and increasing retail expansion.
LOS ANGELES, Feb. 5, 2016 /PRNewswire/ -- Redwood Scientific Technologies, Inc. announced today the development and launch of a new product designed to help women balance their hormones. This product will be featuring Redwood's innovative oral strip delivery technology.
"For too long, women have gone without access to a product that helps them properly balance their hormones," said Jason Cardiff, President and CEO. "I am proud that our company will be able to help the millions of women across the country and around the world who suffer from the effects of imbalanced hormones. Our research and development team is confident that through the use of oral strip delivery technology we can truly impact the lives of women all over the world."
Oral strip delivery technology allows for the immediate delivery of medicinal ingredients into the bloodstream by way of the mouth. When oral strips enter the mouth, they dissolve within seconds and begin entering the circulatory system. In contrast to this, pills, capsules, and liquid medication take several hours to pass through the digestive system in order for their benefits to be felt. Oral strips bypass the digestive system and are not a choking hazard. Additionally, oral strip delivery technology is not as irritating or sneeze-inducing as inhalants.
The all-natural hormone balancing product for women will be formulated to not only increase sexual pleasure but also arousal and stimulation during intercourse. The upcoming product works by increasing blood flow to the erogenous zones and increasing lubrication which in turn allows women to enjoy improved sensitivity. As a result, women who take the upcoming product will be able to have faster and more pleasurable orgasms.
The name of the product and additional details will be revealed before Valentine's Day to coincide with the romantic holiday.
About Redwood Scientific Technologies, Inc.
Redwood Scientific Technologies, Inc. (Redwood), headquartered in Claremont, California, develops and markets FDA registered OTC drugs that can be delivered through the use of thin film technology. Redwood utilizes patent pending sublingual strip delivery technology to enhance the effectiveness and absorption rate in the treatment of medical conditions. The company is aggressively expanding its customer population through national television advertising campaigns while driving consumer awareness and increasing retail expansion.
LOS ANGELES, Oct. 13, 2015 /PRNewswire/ -- Redwood Scientific Technologies, Inc. ("Redwood") today announced it has completed the Food & Drug Administration (FDA) registration process for TBX-FREE to be classified as an over-the-counter homeopathic drug under National Drug Code: 69305-001-01. The completion of the registration process is the result of diligent cooperation with FDA counsel in order to obtain compliance for the key ingredient in TBX-FREE.
"Compliance with FDA regulations is an essential prerequisite to Redwood products being vetted and approved for sale on the shelves of national pharmacy retail locations," said Eunjung Cardiff, Director of Marketing at Redwood. "We expect to announce initial availability of TBX-FREE within the next three months."
TBX-FREE is a thin film stop smoking aid that features cytisine as its key ingredient. Cytisine has the unique property of making smokers feel the same pleasurable sensations as if they were smoking real cigarettes. It also has the power to make smoking cigarettes feel less pleasurable.
"TBX-FREE will be available for purchase without a prescription in the United States, UK, and European markets, allowing smokers access to a thin film technology stop smoking aid that dissolves in seconds and does not contain any nicotine or have any side effects," said Jason Cardiff, President and CEO of Redwood.
In order to gain a foothold in the UK market, Redwood will be running an advertisement for TBX-FREE in the Sun newspaper. Due to the high rates of smoking in the UK and Europe, Sun newspaper readers are likely to be very interested in the benefits of TBX-FREE over traditional tobacco based products like cigarettes. A national infomercial campaign will be launched in the United States later this year in order to inform American smokers about the benefits of TBX-FREE.
The TBX-FREE website can be found at www.TBXFREE.com
About Redwood Scientific Technologies, Inc.
Redwood Scientific Technologies, Inc. (Redwood), headquartered in Claremont, California, develops and markets FDA registered OTC drugs that can be delivered through the use of thin film technology. Redwood utilizes patent pending sublingual strip delivery technology to enhance the effectiveness and absorption rate in the treatment of medical conditions. The company is aggressively expanding its customer population through national television advertising campaigns while driving consumer awareness and increasing retail expansion.
LOS ANGELES, July 31, 2015 /PRNewswire/ -- Redwood Scientific Technologies, Inc. (Redwood) announced today that it has launched a nationwide independent sales representative program for Prolongz: the only FDA registered over-the-counter thin film medication for the treatment of premature ejaculation and erectile dysfunction.
In the coming months, Redwood plans on having multiple independent sales representatives in place throughout every state in the country. Each independent sales representative will be able to earn commissions while establishing and maintaining their own business and revenue through the sale of Prolongz. Redwood has launched its independent sales representative registration page at www.redwoodscientific.co/reps.
"The launch of the Prolongz independent sales representative program is a key milestone for Redwood. Although Prolongz is already sold through many different sales channels, a network of independent sales representatives will provide substantial revenue and scale for the brand. By offering every sales representative a chance to earn money simply by introducing Prolongz to their local convenience and retail stores, Redwood is confident that it will attain immediate and impactful penetration of new locations and marketplaces," said President and CEO Jason Cardiff.
Redwood is offering the independent sales representative opportunity without any cost or investment and will also offer online-based sales support so that representatives can market Prolongz with the confidence and necessary knowledge to close sales.
About Redwood Scientific Technologies, Inc.
Redwood Scientific Technologies, Inc. (Redwood), headquartered in Claremont, California, develops and markets FDA registered OTC drugs that can be delivered through the use of thin film technology. Redwood utilizes patent pending sublingual strip delivery technology to enhance the effectiveness and absorption rate in the treatment of medical conditions. The company is aggressively expanding its customer population through national television advertising campaigns while driving consumer awareness and increasing retail expansion.
LOS ANGELES, July 13, 2015 /PRNewswire/ -- Redwood Scientific Technologies, Inc. (Redwood) today announced the appointment of Rhonda Pearlman as General Counsel effective immediately. She will serve on the company's Executive Leadership Team and will report directly to President and Chief Executive Officer Jason Cardiff.
"Rhonda Pearlman is an experienced and respected attorney with vast experience in the pharmaceutical industry," said Cardiff. "She will be invaluable in the upcoming IPO and in the years ahead as we continue our success with new thin film products that meet the needs of consumers."
As General Counsel, she will manage general corporate matters, debt and equity financing, litigation, and intellectual property.
Ms. Pearlman joins Redwood from the law offices of Stuart L. Melnick, LLC, Kramer Levin Naftalis & Frankel LLP, and Par Pharmaceutical, Inc. where she served as Contract Attorney. She has been an Associate at Baker & McKenzie, Skadden, Arps, Slate, Meagher & Flom LLP & Affiliates, and at Schulte Roth & Zabel LLP. She earned her Bachelors of Science and Masters in Pharmacology as well as her Juris Doctor from the University of Sydney.
About Redwood Scientific Technologies, Inc.
Redwood Scientific Technologies, Inc. (Redwood), headquartered in Claremont, California, develops and markets FDA registered OTC drugs that can be delivered through the use of thin film technology. Redwood utilizes patent pending sublingual strip delivery technology to enhance the effectiveness and absorption rate in the treatment of medical conditions. The company is aggressively expanding its customer population through national television advertising campaigns while driving consumer awareness and increasing retail expansion.
LOS ANGELES, July 7, 2015 /PRNewswire/ -- To aid in the ongoing battle against tobacco-based addiction, Redwood Scientific Technologies, Inc. (Redwood) today announced the launch of TBX-FREE: a new thin film over-the-counter smoking cessation medication that features a key ingredient which mimics the sensation of smoking without any of the harmful side effects.
TBX-FREE has been designed with the intention that cigarette addiction should not be treated with continued nicotine use just as alcoholism should not be treated with reduced amounts of alcohol. TBX-FREE is unique among smoking cessation products because it is devoid of any nicotine.
The key ingredient in TBX-FREE has had its efficiency and efficacy proven by 236 research studies that included clinical trials. It is currently being used for the treatment of nicotine addiction in parts of Asia and Europe.
"We are now proud to be able to synthesize such an incredibly proven ingredient and put it into the form of dissolvable strip delivery technology so that people who suffer with addiction to tobacco-based cigarettes can have over-the-counter access to a smoking cessation treatment that does not use nicotine while enjoying the freedom to live without fear of death," said Jason Cardiff, President and CEO of Redwood, who has made it his mission to combat cigarette addiction in the wake of his mother's death from smoking-related disease.
Ben England, Founder and CEO at FDAImports.com, LLC, will be overseeing the FDA registration process for TBX-FREE.
"We are very excited about the idea of a new treatment to help with nicotine addiction and look forward to working with Redwood and their revolutionary delivery method for the treatment of nicotine addiction," said England.
TBX-FREE will come packaged in the form of discrete thin film containers that look identical to breath freshening strips so that smokers can have it on hand to help quickly address cravings and withdrawal symptoms associated with quitting smoking.
TBX-FREE will be the second product from the Redwood product pipeline and is scheduled to launch in the third quarter of 2016.
About Redwood Scientific Technologies, Inc.
Redwood Scientific Technologies, Inc. (Redwood), headquartered in Claremont, California, develops and markets FDA registered OTC drugs that can be delivered through the use of thin film technology. Redwood utilizes patent pending sublingual strip delivery technology to enhance the effectiveness and absorption rate in the treatment of medical conditions. The company is aggressively expanding its customer population through national television advertising campaigns while driving consumer awareness and increasing retail expansion.
LOS ANGELES, April 8, 2015 /PRNewswire/ -- Redwood Scientific Technologies, Inc. today announced the appointment of Kevin Harrington onto the board of directors, effective immediately. This appointment expands the board to six directors. Kevin Harrington will play an active role overseeing international and domestic retail distribution operations.
"I'm thrilled and excited to be joining the board of directors of Redwood Scientific Technologies," said Kevin Harrington. "I truly believe that what they have developed is a 1 in 10,000 success, not only from a direct-to-consumer standpoint but the future of what thin film delivery technology holds for the delivery of over-the-counter and pharma grade medication. I believe the future of the company is very bright and I look forward to taking an active role in international and domestic retail distribution guiding the company to the success it can be."
President and CEO Jason Cardiff welcomes Kevin Harrington onto the board of directors and expects his retail distribution experience to be invaluable in helping management maintain the company's current growth trajectory.
"As President and CEO of Redwood Scientific Technologies, I am thrilled and excited to have Kevin Harrington and all that he brings to the table join our board of directors," said Jason Cardiff. "I believe that Kevin, along with the other board members, will guide the company and lead us into the future and position us to be the leader in thin film delivery technology."
Kevin Harrington is acknowledged as the inventor of the infomercial and one of the founders of the As Seen On TV products. He is currently the founder of Star Shop LLC. Prior to founding Star Shop LLC., he formed Quantum International which grew to $500 million in sales selling products in 100 countries in 20 languages. He also formed Reliant International Media and HSN Direct in conjunction with Home Shopping Network. He is the founder of ERA (Electronic Retailers Association), which operates in 45 countries, and EO (Entrepreneurs Organization) which boasts combined member sales in excess of $500 billion. In 2009, Kevin Harrington was selected as one of the original Sharks on the ABC hit show "Shark Tank" in which he appeared in over 150 segments. In 1984, Kevin Harrington conceptualized and produced the world's first 30 minute infomercial and in 1980 he started The Small Business Center along with Franchise America. He has been involved in over 500 product launches that have resulted in sales of over $4 billion worldwide with 20 products that have reached individual sales of over $100 million. Kevin Harrington was named one of the 100 best entrepreneurs in the world by Entrepreneur Magazine.
About Redwood Scientific Technologies, Inc.
Redwood Scientific Technologies, Inc., headquartered in Claremont, California, develops and markets FDA registered OTC drugs that can be delivered through the use of thin film technology. Redwood Scientific Technologies, Inc. utilizes patent pending sublingual strip delivery technology to enhance the effectiveness and absorption rate in the treatment of medical conditions. The company is aggressively expanding its customer population through national television advertising campaigns while driving consumer awareness and increasing retail expansion.
LOS ANGELES, Nov. 20, 2014 /PRNewswire/ -- Redwood Scientific Technologies today announced the US launch of Prolongz, the all-natural FDA registered over-the-counter homeopathic drug that helps in the prevention of premature ejaculation. After achieving success with over 100,000 customers outside of the US, Redwood Scientific Technologies has brought Prolongz to the US.
Prolongz ingredients are formulated as a strip that is taken orally and dissolves on the tongue. The formula, a mixture of all-natural products ginseng and damiana, has been tested and proven to increase ejaculatory control and increase intercourse duration.
"Prolongz patented strip technology allows the homeopathic formulation to bypass the first pass metabolism thereby making the dose more bioavailable," says Jason Cardiff, CEO of Redwood Scientific Technologies, LLC. "Seventy-two percent of men ages 18 to 65 experience premature ejaculation, and Prolongz allows for quicker onsets of action at lower doses."
Prolongz can be purchased at GNC retailers nationwide and the company will soon announce further retail distribution partners.
To find out more about Prolongz and to speak confidentially to a representative, please visit www.prolongz.com.
About Redwood Scientific Technologies, LLC
Redwood Scientific Technologies, LLC (RST) was founded by entrepreneur couple Eunjung and Jason Cardiff. Since the company first introduced its flagship product, Prolongz, in December 2013, RST has assisted over 100,000 customers. RST operates under its trademarked logo of a stylized dragon near a flag with foliage along with the slogan, "Be The Dragon." Prolongz is now available at GNC retail locations throughout the United States and will soon be in other national retailers.
LOS ANGELES, Dec. 10, 2014 /PRNewswire/ -- Prolongz, the all-natural FDA registered over-the-counter homeopathic drug that helps in the prevention of premature ejaculation, has been ranked No. 1 in the personal care category for July, August and September of 2014 by the Jordan Whitney Greensheet.
The Jordan Whitney Greensheet provides up-to-date information on Direct Response Television, including infomercials, short-form direct response television commercials, the websites for these products and the companies involved in their production and distribution.
Prolongz ingredients are formulated as a strip that is taken orally and dissolves on the tongue. The formula, a mixture of all-natural products ginseng and damiana, has been tested and proven to increase ejaculatory control and increase intercourse duration. This unique delivery system allows the medication to bypass the first-pass metabolism thereby making the medication more bioavailable and more readily absorbed.
"Prolongz achieving the No. 1 spot three months in a row proves that consumers have a great interest and need for our product," says Jason Cardiff, CEO of Redwood Scientific Technologies. "Having Prolongz available through infomercials was a key strategic decision as the direct response TV market currently dwarfs the cable industry and is expected to exceed $250 billion by 2015."
Prolongz treats males with premature ejaculation, the most common self-diagnosed sexual disorder with 21% of men ages 18 to 65 reporting this issue. The formula has been tested and proved to increase ejaculatory control levels by 97% and triple the length of intercourse.
To find out more about Prolongz and to speak confidentially to a representative, please visit http://prolongz.com/ami.
About Redwood Scientific Technologies, LLC
Redwood Scientific Technologies, LLC (RST) was founded by entrepreneur couple Eunjung and Jason Cardiff. Since the company first introduced its flagship product, Prolongz, in December 2013, RST has assisted over 100,000 customers. RST operates under its trademarked logo of a stylized dragon near a flag with foliage along with the slogan, "Be The Dragon." Prolongz is now available at GNC retail locations throughout the United States and will soon be in other national retailers. For more information please visit http://prolongz.com/ami.
About Jordan Whitney
For over twenty years, Jordan Whitney, Inc., a Tustin, California-based research, consulting and publishing company, has been monitoring, ranking and critiquing direct response television commercials - both infomercials and short-form spot advertisements - as they appear on cable networks and select broadcast stations throughout the United States. Jordan Whitney is the independent "go-to" consulting firm for leading companies in the direct response television industry and retailers who wish to draw upon its extensive database of reviews and analysis of direct response commercials. For more information please visit http://www.jwgreensheet.com.
